- Multiple System Atrophy: Advances in Diagnosis and Therapy
-
Watanabe H, Shima S, Mizutani Y, Ueda A, Ito M
- KMID: 2539017
- J Mov Disord.
- 2023 Jan;16(1):13-21.
- doi: 10.14802/jmd.22082
This review summarizes improvements in understanding the pathophysiology and early clinical symptoms of multiple system atrophy (MSA) and advancements in diagnostic methods and disease-modifying therapies for the condition. In 2022,... -
- CITED
-
- Close
- SHARE
-
- Close
- Drastic Therapy for Listerial Brain Abscess Involving Combined Hyperbaric Oxygen Therapy and Antimicrobial Agents
-
Nakahara K, Yamashita , Ideo K, Shindo S, Suga T, Ueda A, Honda S, Hirahara T, Watanabe M, Yamashita , Maeda Y, Yonemochi , Takita T, Ando Y
- KMID: 2287517
- J Clin Neurol.
- 2014 Oct;10(4):358-362.
- doi: 10.3988/jcn.2014.10.4.358
BACKGROUND: Listeria monocytogenes (L. monocytogenes) is a rare causative pathogen of brain abscess that is often found in immunocompromised patients. Although patients with supratentorial listerial abscesses showed a longer survival... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
-
Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K, Kamijima S, Enomoto T
- KMID: 2537969
- J Gynecol Oncol.
- 2022 Nov;33(6):e78.
- doi: 10.3802/jgo.2022.33.e78
Objective To assess the incidence of bevacizumab-associated gastrointestinal (GI) perforation during first-line treatment of patients with ovarian, fallopian tube, or peritoneal cancer receiving neoadjuvant chemotherapy (NAC) in Japanese real-world clinical practice. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
